Seeking Sustained Growth in Enterprise Value

We continually strive to be a reliable and valued partner in the financial markets. Debt capital investors are key to our financing strategy and success. For your convenience, we’ve provided below a variety of resources including our debt investor presentation as a summary overview, our key ratings and current bonds outstanding.

Our Debt Investor presentation streamlines our key credit-related data into one accessible document.

If you have any further questions related to debt capital, please do not hesitate to contact us.

Bonds Outstanding

Bayer refinances the business mainly through U.S. Dollar and Euro debt capital markets. Below you find a list of all currently outstanding bonds issued by Bayer Group entities. Please note that we cannot provide prospectuses for any of these securities for legal reasons.

Rating

Ratings from internationally recognized agencies allow lenders to assess the risk inherent in financial instruments as companies seek to raise funds in the capital markets by issuing bonds, commercial paper, or other debt instruments. These agencies have confirmed the following ratings, which allow us to access capital markets to issue bonds. With a proven track record of disciplined deleveraging, Bayer remains committed to meeting the “A” target category rating through the long-term.

Debt Investor News

Below you will find all bond-related investor news.